March 18, 2020

Libby Baney Speaks with Informa Pharma Intelligence About CBD Enforcement

Libby Baney was interviewed by Informa Pharma Intelligence for a story about the U.S. Food and Drug Administration (FDA)’s recent report to Congress on the lawful use of cannabidiol (CBD) in food and dietary supplements.

“The report left many searching for more guidance from the agency on what comes next as it does not offer any recommendations around the future of the agency’s oversight of the CBD industry. In so many words, the FDA told Congress: ‘We’re working on it; please stay tuned.'" libby baney

 

Baney added that while the FDA has noted some concerns in connection with CBD, further testing and evaluation are needed, as it would help the industry cooperate with mandates more efficiently.

 

 

 

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.